Lv5
1008 积分 2024-09-18 加入
Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records
1个月前
已完结
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review
1个月前
已完结
Gender differences in lipid management, LDL-C goal attainment, and prescribing practices
1个月前
已关闭
Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease
1个月前
已完结
Racial and ethnic differences in prescribing antihyperglycemic medications to persons with type 2 diabetes: An all of us cohort study
1个月前
已关闭
Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice
1个月前
已完结
Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes at Cardiology, Endocrinology, and Primary Care Visits
1个月前
已关闭
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
1个月前
已完结
Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation
1个月前
已完结
Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome
1个月前
已完结
皖公网安备34019202002308
